Dermata Therapeutics Inc
DRMA
NSC
Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
0.54
USD
0.02
(3.75%)
Optionable: No Market Cap: 5 M 90-day average vol: 1,125,426
Previous close: 0.5205 Open: 0.51 Bid: 0.65 Ask: 0.65
52 week range
0.44 6.95
Peers
Last updated: Thursday 29th September 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 0.00 |
Price per Book TTM ($) | 0.53 |
PE Ratio (TTM) | -0.40 |
Book Value per Share ($) | 0.96 |
5 Year PE Range | -0.6 , -0.7 |
Returns
7 Day Return | -8.47% | |
1 Month Return | -13.57% | |
3 Month Return | -16.94% | |
1 Year Return | -89.26% | |
3 Year Return | -89.60% | |
5 Year Return | -89.60% | |
YTD Return | -68.97% |
Risk
Financial Health
Technicals
RSI (14 Day) | 38.17 |
14 Day SMA ($) | 0.60 |
14 Day EMA ($) | 0.58 |
Money Flow Index | 31.10 |
Average True Range | 0.07 |
50 Day SMA ($) | 0.64 |
200 Day SMA ($) | 1.06 |
ADX | 11.93 |
MACD | -0.04 |
Growth
Free Cash Flow QoQ Growth | 0.00% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | 0.00% |
Revenue QoQ Growth | 0.00% |
EPS YoY Growth | 0.00% |
Profitability
Peers
| Stock | Dividend | Market Cap (B) | PE | Price ($) |
|---|
News
Financials
DRMA Income Statement
Annual
| Invalid date | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | |
| Cost of sales | -1355 | -322 | 0 | |
| Gross operating profit | 0 | 0 | 0 | |
| Selling Gen & administrative expense | 2 M | 2 M | 4 M | |
| Research & development expense | 3 M | 2 M | 3 M | |
| Operating income | -4 M | -3 M | -8 M | |
| floaterest income | 0 | 0 | 0 | |
| floaterest expense | 0 | 0 | 0 | |
| Other income net | 0 | 133592 | 0 | |
| Pre-tax Income (EBT) | -5 M | -3 M | -8 M | |
| Income taxes | 0 | 0 | 0 | |
| Net income from total operations | -5 M | -3 M | -8 M | |
| Minority floaterest | 0 | 0 | 0 | |
| Total net income | -5 M | -3 M | -8 M | |
| Preferred dividends | N/A | N/A | 3 M | |
| Net income available for common | -5 M | -3 M | -10 M | |
| Depreciation | 1355 | 322 | 0 | |
| Amortization | 0 | 0 | 0 | |
| Operating income before depreciation (EBITDA) | -4 M | -3 M | -8 M | |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | |
| Basic EPS total | -0.57 | -0.39 | -2.43 | |
| Diluted EPS total | -0.57 | -0.39 | -2.43 |
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONSGet started today